Abstract
Ocular adnexal lymphoma (OAL) is a rare tumor arising from conjunctiva, orbital soft tissues including extraocular muscles and lacrimal gland, eyelids, and lacrimal sac. The overall incidence rate of primary OAL is 1–2% of all non-Hodgkin’s lymphomas (NHL) and 5–10% of all extranodal NHL with increasing trend noted in recent times. The most popularized classification and staging system for OAL is the American Joint Committee on Cancer (AJCC) TNM (tumor node metastasis) staging. Extranodal marginal zone B-cell lymphoma (EMZL) of mucosa-associated lymphoid tissue (MALT) variant is the most common type of OAL. The clinical presentation of OAL is insidious in onset, painless, slowly progressive, and associated with proptosis, dystopia, ptosis, “Salmon color conjunctival patch” depending on the location and extent of the tumor is characterized by a well-defined mass molding around the globe without any bony changes or globe indentation on imaging.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bardenstein DS. Orbital and adnexal lymphoma. In: Singh A, et al., editors. Clinical ophthalmic oncology. Philadelphia, PA: Saunders-Elsevier; 2007. p. 565–70.
Sjo LD. Ophthalmic lymphoma: epidemiology and pathogenesis. Acta Ophthalmol. 2009;87(1):1–20.
Sjo LD, Ralfkiaer E, Prause JU, et al. Increasing incidence of ophthalmic lymphoma in Denmark from 1980 to 2005. Invest Ophthalmol Vis Sci. 2008;49(8):3283–8.
Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin’s disease staging classification. Cancer Res. 1971;31:1860–1.
Heegaard S, Chevez-Barrios P, White VA, Coupland SE, Finger PT. Ocular Adnexal lymphoma. In: Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al., editors. AJCC cancer staging manual. 8th ed. Cham: Springer International Publishing; 2017. p. 849–54.
Coupland SE, White VA, Rootman JE, et al. A TNM-based clinical staging system of ocular adnexal lymphomas. Arch Pathol Lab Med. 2009;133:1262–7.
Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059–68.
Cheson BD, Ansell S, Schwartz L, et al. Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy. Blood. 2016;128(21):2489–96.
Sjö LD. Ophthalmic lymphoma: epidemiology and pathogenesis. Acta Ophthalmol. 2009;87(1):1–20.
Li JJ, Chen W, Sadeghi N. Conjunctival lymphoma. BMJ Case Rep. 2019;12(7):e229599.
Calvo R, Ribera JM, Vaquero M, et al. Low-grade, malt-type, primary B-cell lymphoma of the conjunctiva. Leuk Lymphoma. 1997;28(1–2):203–7.
Rubin PAD, Kent CJ, Jakobiec FA. Orbital and ocular adnexal lymphoid tumors: Albert & Jakobiec’s principles and practice of ophthalmology. 3rd ed. St Louis, MO: WB Saunders Company, Elsevier; 2018.
Ferry JA, Fung CY, Zukerberg L, et al. Lymphoma of the ocular adnexa: a study of 353 cases. Am J Surg Pathol. 2007;31(2):170–84.
Oh DE, Kim YD. Lymphoproliferative diseases of the ocular adnexa in Korea. Arch Ophthalmol. 2007;125(12):1668–73.
Ozkan MC, Palamar M, Tombuloglu M, et al. Ocular adnexal lymphomas: single-center experience. Clin Lymphoma Myeloma Leuk. 2015;15(Suppl):S158–60.
Streubel B, Lamprecht A, Dierlamm J, et al. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood. 2003;101:2335–9.
Streubel B, Vinatzer U, Lamprecht A, Raderer M, Chott A. T(3; 14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia. 2005;19:652–8.
Verdijk RM. Lymphoproliferative tumors of the ocular adnexa. Asia Pac J Ophthalmol. 2017;6(2):132–42.
Shields JA, Saunders WB. Lymphoid tumors and leukemias. Diagnosis and management of orbital tumors. 1st ed. Philadelphia, PA: J.B. Lippincott; 1989.
Watkins LM, Carter KD, Nerad JA. Ocular adnexal lymphoma of the extraocular muscles: case series from the University of Iowa and review of the literature. Ophthal Plast Reconstr Surg. 2011;27:471–6.
Gill MK, Jampol LM. Variations in the presentation of primary intraocular lymphoma: case reports and a review. Surv Ophthalmol. 2001;45:463–71.
Kuro M, Matsuyama K, Matsuoka M, et al. Case of primary intraocular lymphoma with extraocular extension. Ocul Oncol Pathol. 2015;2(2):66–70.
Demirci H, Shields C, Shields J, et al. Orbital tumors in the older adult population. Ophthalmology. 2002;109:243–8.
Coupland SE, Damato B. Lymphomas involving the eye and the ocular adnexa. Curr Opin Ophthalmol. 2006;17:523–31.
Knowles DM, Jakobiec FA, McNally L, et al. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol. 1990;21:959–73.
Olsen TG, Heegaard S. Orbital lymphoma. Surv Ophthalmol. 2019;64(1):45–66.
Charton J, Witherspoon SR, Itani K, et al. Natural killer/T-cell lymphoma masquerading as orbital cellulitis. Ophthal Plast Reconstr Surg. 2008;24(2):143–5.
Cassidy DT, McKelvie P, Harris GJ, et al. Lacrimal gland orbital lobe cysts associated with MALT lymphoma and primary Sjogren’s syndrome. Orbit. 2005;24(4):257–63.
Coupland SE, Foss HD, Hummel M, et al. Extranodal marginal zone B-cell lymphoma of the lacrimal gland associated with crystal-storing histiocytosis. Ophthalmology. 2002;109(1):105–10.
Bertelmann E, Minko N. Safety of the preoperative evaluation of pleomorphic adenoma: a retrospective analysis. Klin Monatsbl Augenheilkd. 2012;229(3):231–5.
Coupland SE, Hellmich M, Auw-Haedrich C, et al. Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases. Graefes Arch Clin Exp Ophthalmol. 2004;242:130–45.
Coupland SE, Krause L, Delecluse HJ, et al. Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology. 1998;105:1430–41.
Fung CY, Tarbell NJ, Lucarelli MJ, et al. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes. Int J Radiat Oncol Biol Phys. 2003;57:1382–91.
McKelvie PA, McNab A, Francis IC, et al. Ocular adnexal lymphoproliferative disease: a series of 73 cases. Clin Exp Ophthalmol. 2001;29:387–93.
Meunier J, Lumbroso-Le Rouic L, Vincent-Salomon A, et al. Ophthalmologic and intraocular non-Hodgkin’s lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factors. Hematol Oncol. 2004;22:143–58.
Sullivan TJ, Whitehead K, Williamson R, et al. Lymphoproliferative disease of the ocular adnexa: a clinical and pathologic study with statistical analysis of 69 patients. Ophthal Plast Reconstr Surg. 2005;21:177–88.
Alkatan HM, Alaraj A, El-Khani A, et al. Ocular adnexal lymphoproliferative disorders in an ophthalmic referral center in Saudi Arabia. Saudi J Ophthalmol. 2013;27:227–30.
Berry-Brincat A, Tomlins P, Hall A, et al. Primary extrasac orbital lymphoma presenting as nasolacrimal obstruction. Orbit. 2008;27(3):175–7.
Mashayekhi A, Shukla SY, Shields JA, et al. Choroidal lymphoma: clinical features and association with systemic lymphoma. Ophthalmology. 2014;121(1):342–51.
Shields CL, Shields JA, Carvalho C, Rundle P, Smith AF. Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship to systemic lymphoma. Ophthalmology. 2001;108(5):979–84.
Demirci H, Shields CL, Karatza EC, et al. Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases. Ophthalmology. 2008;115(9):1626–31.
Vempuluru VS, Jakati S, Godbole A, et al. Spectrum of AS-OCT features of ocular surface tumors and correlation of clinico-tomographic features with histopathology: a study of 70 lesions. Int Ophthalmol. 2021;41(11):3571–86.
Naik MN, Tourani KL, Sekhar GC, et al. Interpretation of computed tomography imaging of the eye and orbit: a systematic approach. Indian J Ophthalmol. 2002;50:339–53.
Sullivan TJ, Valenzuela AA. Imaging features of ocular adnexal lymphoproliferative disease. Eye. 2006;20:1189–95.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bejjanki, K.M., Kaliki, S. (2023). Ocular Adnexal Lymphoma: Clinical Presentation and Imaging Studies. In: Raval, V.R., Mruthyunjaya, P., Singh, A.D. (eds) Ocular and Adnexal Lymphoma. Essentials in Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-031-24595-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-031-24595-4_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-24594-7
Online ISBN: 978-3-031-24595-4
eBook Packages: MedicineMedicine (R0)